Not Yet Recruiting PHASE1 INTERVENTIONAL 1-arm
NCT06881732
Experimental Malaria Infection of Healthy Malaria-Naive Adults by Mosquito Bite With the Genetically Modified Plasmodium Falciparum NF54/iGP3 GAP (iGP3-SWITCH)
Sponsor: QIMR Berghofer Medical Research Institute
Interventions
NF54/iGP3
Updated 2 times since 2025 Last updated: Mar 11, 2025 Started: Jul 31, 2025 Primary completion: Jul 31, 2026 Completion: Jul 31, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT06881732, this PHASE1 trial focuses on Malaria Falciparum and Malaria Infection and remains actively recruiting participants. Sponsored by QIMR Berghofer Medical Research Institute, it has been updated 2 times since 2025, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
2 versions recorded-
Jun 2025 — Present [monthly]
Not Yet Recruiting PHASE1
-
Apr 2025 — Jun 2025 [monthly]
Not Yet Recruiting PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- QIMR Berghofer Medical Research Institute
- Swiss Tropical & Public Health Institute
- University of Melbourne
- Walter and Eliza Hall Institute of Medical Research
Data source: University of Melbourne
For direct contact, visit the study record on ClinicalTrials.gov .